Professional overview
Li Xianliang is a Chief Physician and Associate Professor in the Department of Hepatobiliary and Pancreatic Surgery at Beijing Chao-Yang Hospital. Clinical work focuses on comprehensive treatment of hepatobiliary and pancreatic malignancies, minimally invasive surgery for hepatobiliary and pancreatic diseases, and immunoregulatory management of organ transplantation including liver transplantation.
Areas of focus
Clinic days
From the hospital website, checked 2026-11-19. Schedules change, so check before you go.
Background
- 1994Graduated from China Medical University
- 1997Earned Master's degree from China Medical University
- 2000Visiting scholar at Queen Mary Hospital, The University of Hong Kong, supported by the Sir Yue-Kong Pao Fellowship
- 2004PhD candidate under Academician Fan Shangda at The University of Hong Kong
- 2005Postdoctoral research in France
- 2006Awarded Transplantation Society (TTS) Research Fellowship at the World Transplant Congress in Boston
- 2008Awarded ESOT Senior Research Grant at the European Society of Organ Transplantation (ESOT) Annual Meeting in Paris; served as Co-Chair of the Clinical Immune Tolerance Session and delivered an invited presentation at the World Transplant Congress in Sydney
- 2010Joined the Department of Hepatobiliary and Pancreatic Surgery at Beijing Chaoyang Hospital as an overseas-trained talent; organized the China-France Symposium on Transplantation Immune Tolerance
- 2011Delivered an invited presentation at the China-Canada Summit on Comprehensive Cancer Treatment
Experience & recognition
- Awarded TTS Research Fellowship (2006, Boston)
- Awarded ESOT Senior Research Grant (2008, Paris)
- Co-Chair of Clinical Immune Tolerance Session, World Transplant Congress (2008, Sydney)
- Organized China-France Symposium on Transplantation Immune Tolerance (2010)
- Invited presenter at China-Canada Summit on Comprehensive Cancer Treatment (2011)
- Published 63 articles, book chapters, and conference abstracts; 20 published in SCI-indexed journals and conferences with cumulative impact factor >110 and ~300 citations
- Served as editorial board member for Liver Cancer, American Journal of Immunology, and The Open Surgery Journal
- Served as peer reviewer for Hepatobiliary & Pancreatic Diseases International, Journal of Asthma and Allergy, International Journal of Biomedical Science, and Intensive Care Medicine
Professional roles
- Member, Chinese Medical Association (CMA)
- Member, Chinese Medical Doctor Association (CMDA)
- Member, China Anti-Cancer Association (CACA)
- Member, Chinese Association of Integrative Medicine (CAIM)
- Member, European Society of Organ Transplantation (ESOT)
- Member, The Transplantation Society (TTS)
- Member, French Dendritic Cell Club
- Reviewer, National Natural Science Foundation of China (NSFC)
Frequently asked questions
What does Dr. Li Xianliang specialize in?
Comprehensive treatment of liver cancer, pancreatic cancer, and cholangiocarcinoma; minimally invasive surgery for hepatobiliary and pancreatic diseases; immunoregulatory management and liver transplantation surgery
Which hospital and department is Dr. Li Xianliang in?
Department of Hepatobiliary and Pancreatic Surgery at Beijing Chao-Yang Hospital
Sources
- Compiled from public information about the doctor's clinical title, department and areas of focus, rewritten by Find China Doctors.
- Medical licence: National Health Commission doctor registry
Dr. Li Xianliang has not reviewed this page.

